- Nurofen and Dettel manufacturer Reckitt warns of potential £150m hit from Iran war oil costs Yorkshire Post —
- Dettol maker Reckitt warns of lower margins after quarterly sales miss Irish Times —
- Reckitt shares slump as Durex owner takes £150m Iran war hit City AM —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Standard —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand The Independent —
- Reckitt cautions over impact of Iran war on costs and consumer demand Belfast Telegraph —
- Reckitt Sales Hit by Lackluster US Demand for Cold Medicines Bloomberg —
- Reckitt’s Like-for-Like Revenue Rises on Emerging Markets Performance Wall Street Journal —
- Reckitt cautions over impact of Iran war on costs and consumer demand LBC —
Reckitt Warns of War Costs
Reckitt's shares slumped following the announcement, as the company struggles with supply chain disruptions in the Middle East and the impact of EU sanctions on its Russia business.
The firm noted that higher raw material costs are likely to be passed on to consumers, further fueling global inflation concerns.
Despite these challenges, Reckitt saw strong performance in emerging markets, where like-for-like sales grew by over 7%.
The company is now focusing on cost-cutting measures and strategic pivots to protect its margins through the remainder of the fiscal year.